Premium
Detection of primary and metastatic lesions by [ 18 F]fluoro‐2‐deoxy‐D‐glucose PET in a patient with thymic carcinoid
Author(s) -
FUJISHITA Takashi,
KISHIDA Mika,
TAKI Hirofumi,
SHINODA Chie,
MIYABAYASHI Koutarou,
FUJISHITA Masayo,
MARUYAMA Muneharu,
MIZUSHIMA Yutaka,
KOBAYASHI Masashi
Publication year - 2007
Publication title -
respirology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.857
H-Index - 85
eISSN - 1440-1843
pISSN - 1323-7799
DOI - 10.1111/j.1440-1843.2007.01161.x
Subject(s) - medicine , scintigraphy , nuclear medicine , positron emission tomography , radiology
We present a case of thymic carcinoid, in which primary and metastatic lesions of lymph nodes and bones could be detected by [ 18 F]fluoro‐2‐deoxy‐D‐glucose (FDG)‐PET, but not by 123 I‐meta‐iodobenzylguanidine ( 123 I‐MIBG) SPECT, or by 99m Tc‐methylene diphosphonate ( 99m Tc‐MDP) bone scintigraphy. FDG‐PET may be a useful tool for managing thymic carcinoids in patients with negative results on 123 I‐MIBG SPECT or 99m Tc‐MDP imaging.